Clinical Trials on Arterial Access in Belgium

Total 843 results

Sanofi

Completed

Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent Claudication (TALISMAN 211)

Peripheral Arterial Occlusive Disease

United States, Belgium, Germany, Switzerland
GlaxoSmithKline

Completed

Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.

Streptococcus Agalactiae | Bacterial Infection Due to Streptococcus, Group B

Belgium
Flanders Medical Research Program

Completed

Physician-Initiated Trial Investigating the BeGraft Peripheral Stent Graft System

Peripheral Vascular Disease

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults

Tuberculosis

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies

Idiopathic Pulmonary Arterial Hypertension

Belgium
University Hospital, Antwerp

Completed

Neuromonitoring During Rapid Ventricular Pacing in Patients Undergoing Cerebral Aneurysm Surgery

Cerebral Arterial Aneurysm | Ventricular Rate Response Pacing

Belgium
GlaxoSmithKline

Completed

Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults

Pneumococcal Disease

Belgium
Minervax ApS
Iqvia Pty Ltd

Completed

Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants

Group B Streptococcal Infections

Belgium
Flanders Medical Research Program
Medtronic Neurovascular Clinical Affairs

Completed

DURABILITY+ : a Prospective, Multi-center, Controlled Study With the Everflex+ Stent in SFA Lesions (DURABILITY+)

Peripheral Arterial Disease

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.

Tuberculosis (TB)

Belgium
GlaxoSmithKline

Completed

Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

Infections, Meningococcal

Belgium
Flanders Medical Research Program

Completed

Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlusion (ROBINSON)

Peripheral Vascular Disease

Belgium
GlaxoSmithKline

Completed

Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years

Infections, Meningococcal

Belgium
GlaxoSmithKline
Aeras

Completed

Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342

Tuberculosis

Belgium
QualiMed Innovative Medizinprodukte GmbH

Not yet recruiting

Safety and Efficacy of the QBX Peripheral Balloon Expandable Stent System in Peripheral Artery Disease (PAD) (QBX-RADAR)

Peripheral Arterial Disease

Belgium
ID3 Medical

Active, not recruiting

Belgian Trial Investigating the LifeStream Stent in Complex TASC C and D Iliac Lesions (BELSTREAM)

Peripheral Arterial Disease

Belgium
Flanders Medical Research Program

Completed

DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions

Intermittent Claudication | Peripheral Vascular Disease | Critical Limb Ischemia

Belgium
Centre Hospitalier Universitaire Saint Pierre

Suspended

Role of EBUS-TBNA in Diagnosing TB in Mediastinal/Hilar Lymph Nodes

Tuberculosis

Belgium
University Ghent

Completed

Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis (LACRING01)

Vaginosis, Bacterial

Belgium
GlaxoSmithKline

Completed

Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.

Prophylactic Pneumococcal Diseases

Belgium
Institute of Tropical Medicine, Belgium

Completed

Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea (ResistAZM)

Neisseria Gonorrhoeae

Belgium
GlaxoSmithKline

Completed

Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults

Infections, Streptococcal

Belgium
GlaxoSmithKline

Completed

Evaluation of Pneumococcal Vaccine Formulations in Young Adults

Infections, Streptococcal

Belgium
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults

Infections, Staphylococcal

Belgium
Flanders Medical Research Program

Unknown

The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions (ZILVERPASS)

Peripheral Vascular Disease

Belgium
GlaxoSmithKline
Biological E. Limited

Recruiting

Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults

Typhoid Fever

Belgium
Université Catholique de Louvain

Recruiting

Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units (Pop-PK/PD)

Pharmacokinetics | Infection | Infection, Bacterial | Anti-Bacterial Agents | Drug Monitoring | Infections, Respiratory

Belgium
Institute of Tropical Medicine, Belgium
University Hospital, Antwerp

Completed

Treponema Pallidum-specific Proteomic Changes in Patients With Incident Syphilis Infection (SeTPAT)

Syphilis

Belgium
Algemeen Ziekenhuis Maria Middelares

Unknown

Effect of Phenylephrine Versus Norepinephrine on Venous Return

Arterial Hypotension

Belgium
University Hospital, Ghent

Recruiting

Antibiotic Dosing in Geriatric Patients at the Emergency Department (AGED)

Frail Elderly Syndrome | Frailty | Infection, Bacterial | Elderly Infection

Belgium
University Hospital, Antwerp

Completed

Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of In-stent Restenosis

Atherosclerosis | Restenosis

Belgium
Flanders Medical Research Program

Completed

Clear-Road Trial, Investigating the Efficacy of the RoadSaver Stent

Peripheral Arterial Disease

Belgium
Provascular GmbH
William Cook Europe

Completed

Evaluation of Paclitaxel Eluting Stent vs Paclitaxel Eluting Balloon Treating Peripheral Artery Disease of the Femoral Artery

Peripheral Artery Disease

Belgium, Germany
Universitaire Ziekenhuizen KU Leuven

Completed

Coagulation and Fibrinolysis as Virulence Factors for Invasive Staphylococcus Aureus and Streptococcus Infections

Infective Endocarditis | Necrotizing Fasciitis

Belgium
Flanders Medical Research Program

Completed

Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Stenotic Disease With the Biotronik Passeo-18 Lux Drug Releasing Balloon and the Biotronik Pulsar-18 Stent (Comparing With 4EVER Trial Results) (BIOLUX 4EVER)

Peripheral Vascular Disease

Belgium
Institute of Tropical Medicine, Belgium
Novosanis NV

Completed

Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs (Colli-Pee)

Sexually Transmitted Diseases, Bacterial

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia

Staphylococcus Aureus Bacteraemia

Belgium
Flanders Medical Research Program

Unknown

In.Pact Flexion, Investigating the Performance of the In.Pact Admiral DEB for Popliteal Lesions (INPCTFLEXION)

Peripheral Arterial Disease

Belgium
Sciensano
Merck Sharp & Dohme LLC; Pfizer; Universitaire Ziekenhuizen KU Leuven

Recruiting

Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium (STREPTO)

Pneumonia | Otitis Media | Sinusitis Bacterial

Belgium
Novartis

Completed

Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults

Typhoid Fever

Belgium
Erasme University Hospital

Completed

Efficacy Study of Rapid Test to Prevent Hospital Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA)

Staphylococcus Aureus | Staphylococcal Infection | Methicillin Resistance

Belgium
GlaxoSmithKline

Completed

Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States

Whooping Cough

Belgium
GlaxoSmithKline

Completed

Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population

Prophylaxis Invasive Pneumococcal Diseases and Pneumonia

Belgium
ID3 Medical

Completed

Clinical Trial Investigating the Combination Therapy With Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Lesions (TINTIN)

Peripheral Arterial Disease

Belgium
Novartis Pharmaceuticals
University of Pennsylvania

Recruiting

CAR-T Long Term Follow Up (LTFU) Study (PAVO)

Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program

United States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
Flanders Medical Research Program

Completed

Single Arm Study With a Nitinol Self-Expanding Paclitaxel-Eluting Stent to Treat BTK Arteries (PES-BTK-70)

Peripheral Arterial Disease

Belgium
Biotronik AG

Completed

BIOLUX P-III BENELUX All-Comers Registry

Peripheral Arterial Disease

Netherlands, Belgium, Luxembourg
ID3 Medical

Active, not recruiting

Clinical Trial Investigating the BeGraft Peripheral Plus Stent Graft System for Iliac Lesion Treatment (BeGraft+PMCF)

Peripheral Arterial Disease

Belgium, France
Pfizer

Terminated

A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin (PROSE)

Pulmonary Arterial Hypertension

Belgium, Germany, France
University Hospital, Ghent
Research Foundation Flanders

Recruiting

Decolonization of Gram-negative Multi-resistant Organisms (MDRO) With Donor Microbiota (FMT) (DEKODON)

Resistance Bacterial

Belgium

3

Subscribe